185 related articles for article (PubMed ID: 34575580)
1. A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices.
Abraham MK; Jost E; Hohmann JD; Searle AK; Bongcaron V; Song Y; Wendel HP; Peter K; Krajewski S; Wang X
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575580
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
3. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
4. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
[TBL] [Abstract][Full Text] [Related]
6. Ectonucleoside Triphosphate Diphosphohydrolase-1/CD39 Affects the Response to ADP of Female Rat Platelets.
Caiazzo E; Bilancia R; Rossi A; Ialenti A; Cicala C
Front Pharmacol; 2019; 10():1689. PubMed ID: 32082171
[TBL] [Abstract][Full Text] [Related]
7. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
8. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
[TBL] [Abstract][Full Text] [Related]
9. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
Takemoto Y; Kawata H; Soeda T; Imagawa K; Somekawa S; Takeda Y; Uemura S; Matsumoto M; Fujimura Y; Jo J; Kimura Y; Tabata Y; Saito Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):857-62. PubMed ID: 19325141
[TBL] [Abstract][Full Text] [Related]
10. Activated-platelet targeting of CD39 as a potential way forward. The quest for efficient antithrombotic therapy without associated bleeding complications.
Hohmann JD; Peter K
Hamostaseologie; 2016; 36(1):17-25. PubMed ID: 26328528
[TBL] [Abstract][Full Text] [Related]
11. Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study.
Granja T; Körner A; Glück C; Hohmann JD; Wang X; Köhler D; Streißenberger A; Nandurkar HH; Mirakaj V; Rosenberger P; Peter K; Straub A
Crit Care Med; 2019 May; 47(5):e420-e427. PubMed ID: 30730441
[TBL] [Abstract][Full Text] [Related]
12. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries.
Gangadharan SP; Imai M; Rhynhart KK; Sévigny J; Robson SC; Conte MS
Surgery; 2001 Aug; 130(2):296-303. PubMed ID: 11490363
[TBL] [Abstract][Full Text] [Related]
13. In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.
Abraham MK; Nolte A; Reus R; Behring A; Zengerle D; Avci-Adali M; Hohmann JD; Peter K; Schlensak C; Wendel HP; Krajewski S
PLoS One; 2015; 10(9):e0138375. PubMed ID: 26381750
[TBL] [Abstract][Full Text] [Related]
14. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
[TBL] [Abstract][Full Text] [Related]
15. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
[TBL] [Abstract][Full Text] [Related]
17. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
18. The role of the CD39-CD73-adenosine pathway in liver disease.
Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
[TBL] [Abstract][Full Text] [Related]
19. Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism.
Spatola BN; Lerner AG; Wong C; Dela Cruz T; Welch M; Fung W; Kovalenko M; Losenkova K; Yegutkin GG; Beers C; Corbin J; Soros VB
MAbs; 2020; 12(1):1838036. PubMed ID: 33146056
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
